Nationwide cloud-based integrated database of idiopathic interstitial pneumonias for multidisciplinary discussion.


Journal

The European respiratory journal
ISSN: 1399-3003
Titre abrégé: Eur Respir J
Pays: England
ID NLM: 8803460

Informations de publication

Date de publication:
05 2019
Historique:
received: 26 11 2018
accepted: 04 03 2019
pubmed: 19 3 2019
medline: 29 10 2020
entrez: 19 3 2019
Statut: epublish

Résumé

Multidisciplinary discussion (MDD) requiring close communication between specialists (clinicians, radiologists and pathologists) is the gold standard for the diagnosis of idiopathic interstitial pneumonias (IIPs). However, MDD by specialists is not always feasible because they are often separated by time and location. An online database would facilitate data sharing and MDD. Our aims were to develop a nationwide cloud-based integrated database containing clinical, radiological and pathological data of patients with IIPs along with a web-based MDD system, and to validate the diagnostic utility of web-based MDD in IIPs.Clinical data, high-resolution computed tomography images and lung biopsy slides from patients with IIPs were digitised and uploaded to separate servers to develop a cloud-based integrated database. Web-based MDD was performed using the database and video-conferencing to reach a diagnosis.Clinical, radiological and pathological data of 524 patients in 39 institutions were collected, uploaded and incorporated into the cloud-based integrated database. Subsequently, web-based MDDs with a pulmonologist, radiologist and pathologist using the database and video-conferencing were successfully performed for the 465 cases with adequate data. Overall, the web-based MDD changed the institutional diagnosis in 219 cases (47%). Notably, the MDD diagnosis yielded better prognostic separation among the IIPs than did the institutional diagnosis.This is the first study of developing a nationwide cloud-based integrated database containing clinical, radiological and pathological data for web-based MDD in patients with IIPs. The database and the web-based MDD system that we built made MDD more feasible in practice, potentially increasing accurate diagnosis of IIPs.

Identifiants

pubmed: 30880283
pii: 13993003.02243-2018
doi: 10.1183/13993003.02243-2018
pmc: PMC6853800
pii:
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright ©ERS 2019.

Déclaration de conflit d'intérêts

Conflict of interest: T. Fujisawa has nothing to disclose. Conflict of interest: K. Mori has nothing to disclose. Conflict of interest: M. Mikamo has nothing to disclose. Conflict of interest: T. Ohno has nothing to disclose. Conflict of interest: K. Kataoka has nothing to disclose. Conflict of interest: C. Sugimoto has nothing to disclose. Conflict of interest: H. Kitamura has nothing to disclose. Conflict of interest: N. Enomoto has nothing to disclose. Conflict of interest: R. Egashira has nothing to disclose. Conflict of interest: H. Sumikawa has nothing to disclose. Conflict of interest: T. Iwasawa has nothing to disclose. Conflict of interest: S. Matsushita has nothing to disclose. Conflict of interest: H. Sugiura receives honoraria for consultancy services from Ono Pharmaceutical Co., Ltd, Bristol-Myers Squibb KK and MSD KK. Conflict of interest: M. Hashisako has nothing to disclose. Conflict of interest: T. Tanaka has nothing to disclose. Conflict of interest: Y. Terasaki has nothing to disclose. Conflict of interest: S. Kunugi has nothing to disclose. Conflict of interest: M. Kitani has nothing to disclose. Conflict of interest: R. Okuda has nothing to disclose. Conflict of interest: Y. Horiike has nothing to disclose. Conflict of interest: Y. Enomoto has nothing to disclose. Conflict of interest: H. Yasui has nothing to disclose. Conflict of interest: H. Hozumi has nothing to disclose. Conflict of interest: Y. Suzuki has nothing to disclose. Conflict of interest: Y. Nakamura has nothing to disclose. Conflict of interest: J. Fukuoka has nothing to disclose. Conflict of interest: T. Johkoh has nothing to disclose. Conflict of interest: Y. Kondoh has nothing to disclose. Conflict of interest: T. Ogura has nothing to disclose. Conflict of interest: Y. Inoue reports fees for advisory board work and lecturing from Boehringer Ingelheim, outside the submitted work. Conflict of interest: Y. Hasegawa has nothing to disclose. Conflict of interest: N. Inase has nothing to disclose. Conflict of interest: S. Homma has nothing to disclose. Conflict of interest: T. Suda has nothing to disclose.

Références

Ann Am Thorac Soc. 2018 Jul;15(7):854-863
pubmed: 29779392
Lancet Respir Med. 2014 Nov;2(11):933-942
pubmed: 25439569
JAMA. 1982 May 14;247(18):2543-6
pubmed: 7069920
Comput Methods Programs Biomed. 2014;113(1):266-83
pubmed: 24183386
Curr Opin Pulm Med. 2018 Sep;24(5):461-468
pubmed: 30004990
Am J Respir Crit Care Med. 2004 Oct 15;170(8):904-10
pubmed: 15256390
Respir Med. 2017 Dec;133:1-5
pubmed: 29173442
Respir Med. 2018 Aug;141:190-197
pubmed: 30053966
Eur Respir J. 2012 Aug;40(2):377-85
pubmed: 22441748
N Engl J Med. 2018 May 10;378(19):1811-1823
pubmed: 29742380
Eur Respir J. 2008 Mar;31(3):585-91
pubmed: 18057059
Lancet Respir Med. 2017 Jan;5(1):61-71
pubmed: 27932290
Am J Respir Crit Care Med. 2002 Jan 15;165(2):277-304
pubmed: 11790668
Lancet Respir Med. 2016 Jul;4(7):557-565
pubmed: 27180021
Radiographics. 2007 Jul-Aug;27(4):1201-11
pubmed: 17620477
J Clin Med. 2016 Jul 27;5(8):null
pubmed: 27472372
Respirology. 2017 Apr;22(3):494-500
pubmed: 28297158
Can Respir J. 2018 Aug 13;2018:6043053
pubmed: 30186537
BMC Pulm Med. 2012 Dec 05;12:72
pubmed: 23216996
Am J Respir Crit Care Med. 2011 Mar 15;183(6):788-824
pubmed: 21471066
Eur Respir J. 2015 Oct;46(4):976-87
pubmed: 26160873
Am J Respir Crit Care Med. 1998 Jan;157(1):199-203
pubmed: 9445300
Am J Respir Crit Care Med. 2018 Sep 1;198(5):e44-e68
pubmed: 30168753
Chest. 2018 Jun;153(6):1416-1423
pubmed: 29608882
Eur Respir J. 2013 Sep;42(3):750-7
pubmed: 23222877
Respirology. 2016 Nov;21(8):1438-1444
pubmed: 27427515
Am J Respir Crit Care Med. 2013 Sep 15;188(6):733-48
pubmed: 24032382

Auteurs

Tomoyuki Fujisawa (T)

Second Division, Dept of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan fujisawa@hama-med.ac.jp.

Kazutaka Mori (K)

Second Division, Dept of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.

Masashi Mikamo (M)

Second Division, Dept of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.

Takashi Ohno (T)

Esite Healthcare Co., Ltd, Tokyo, Japan.

Kensuke Kataoka (K)

Dept of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Japan.

Chikatoshi Sugimoto (C)

Clinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, Japan.

Hideya Kitamura (H)

Dept of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Japan.

Noriyuki Enomoto (N)

Second Division, Dept of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.

Ryoko Egashira (R)

Dept of Radiology, Faculty of Medicine, Saga University, Saga, Japan.

Hiromitsu Sumikawa (H)

Dept of Radiology, Sakai City Medical Center, Sakai, Japan.

Tae Iwasawa (T)

Dept of Radiology, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Japan.

Shoichiro Matsushita (S)

Dept of Radiology, St Marianna University School of Medicine, Kawasaki, Japan.

Hiroaki Sugiura (H)

Dept of Radiology, Keio University School of Medicine, Tokyo, Japan.

Mikiko Hashisako (M)

Division of Diagnostic Pathology, Kyushu University Hospital, Fukuoka, Japan.

Tomonori Tanaka (T)

Dept of Pathology, Kindai University Faculty of Medicine, Osaka, Japan.

Yasuhiro Terasaki (Y)

Dept of Analytic Human Pathology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan.

Shinobu Kunugi (S)

Dept of Analytic Human Pathology, Graduate School of Medicine, Nippon Medical School, Tokyo, Japan.

Masashi Kitani (M)

Dept of Pathology, National Hospital Organization Tokyo National Hospital, Tokyo, Japan.

Ryo Okuda (R)

Dept of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Japan.

Yasuoki Horiike (Y)

Second Division, Dept of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.

Yasunori Enomoto (Y)

Second Division, Dept of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.

Hideki Yasui (H)

Second Division, Dept of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.

Hironao Hozumi (H)

Second Division, Dept of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.

Yuzo Suzuki (Y)

Second Division, Dept of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.

Yutaro Nakamura (Y)

Second Division, Dept of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.

Junya Fukuoka (J)

Dept of Pathology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

Takeshi Johkoh (T)

Dept of Radiology, Kinki Central Hospital of Mutual Aid Association of Public-School Teachers, Itami, Japan.

Yasuhiro Kondoh (Y)

Dept of Respiratory Medicine and Allergy, Tosei General Hospital, Seto, Japan.

Takashi Ogura (T)

Dept of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Japan.

Yoshikazu Inoue (Y)

Clinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, Japan.

Yoshinori Hasegawa (Y)

Dept of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Naohiko Inase (N)

Dept of Respiratory Medicine, Tokyo Medical and Dental University, Tokyo, Japan.

Sakae Homma (S)

Dept of Respiratory Medicine, Toho University Omori Medical Center, Tokyo, Japan.

Takafumi Suda (T)

Second Division, Dept of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH